Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial
Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0, indicating a system/template update across the page.SummaryDifference0.0%

- Check24 days agoChange DetectedPage revision note updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check39 days agoChange DetectedA new citation for SARS-CoV-2 resistance analyses from the Phase 3 BIRCH study was added, and the earlier version of that citation was removed.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Clin Infect Dis publication on BIRCH (2026) and removed older funding notice.SummaryDifference0.3%

- Check60 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH operating status with links to cc.nih.gov and opm.gov. Updated the site to revision v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check67 days agoChange DetectedThe page now includes a glossary option, adds a new cited publication (SARS-CoV-2 Resistance Analyses...), and updates several metadata labels including QC-related entries and the revision tag.SummaryDifference0.2%

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.